GGrantIndex
← Search

DEVELOPMENT AND EVALUATION OF A CARE PATHWAY FOR EVALUATION AND MANAGEMENT OF THE RESPIRATORY SYNDROMES OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) [CAPRESA]

$2,311,734FY2025Defense Health AgencyDOD

Denver Research Institute, Denver CO

Investigators

View source on USAspending →